2026 FDLI Annual Conference
May 6–7, 2026 | Washington, DC & Virtual Event
Overview
Conference Highlights
- Hear FDA’s strategic priorities directly from the FDA Commissioner and other key leaders within the agency and Health and Human Services invited to speak
- Join high-level colleagues in food and drug law to hear different viewpoints, shape policy, and advance understanding
- Participate in over 30 sessions covering the latest in legal, regulatory, compliance, policy, marketing, and related issues to enjoy targeted for your key interests
- Learn from more than 100 well-known officials and experts
- Hear about the Top Cases in Food and Drug Law
- Network and build relationships with seasoned legal, regulatory, compliance, policy, and government professionals
Register
Call for Proposals
Sponsors
Premier
Platinum
Diamond
Gold
Silver
Bronze
Lanyard
Planning Committee

Kalah Auchincloss
Co-Chair
Auchincloss Legal

Sharon Mayl
Co-Chair
DLA Piper LLP (US)
Committee Members
Anna K. Abram, Akin
Laura J. Akowuah, Cooley LLP
John Claud, Nelson Mullins Riley & Scarborough LLP
Andrea G. Ferrenz, The Campbell’s Company
Eric Fish, ProPharma Group
Jack C. Garvey, Compliance Architects LLC
Lewis A. Grossman, American University
Dorothy K. Hatsukami, University of Minnesota
Matthew Hegreness, Covington & Burling LLP
Jeremiah J. Kelly, Venable LLP
Coleen E. Klasmeier, Roche Diagnostics/BMC
Paige Magness, Altria Client Services LLC
Rachael G. Pontikes, Blank Rome, LLP
Margaret (Mimi) Foster Riley, University of Virginia
Schevon Salmon, K&L Gates LLP
Ariel Seeley, Morgan, Lewis & Bockius LLP
Lance L. Shea, Foley Hoag LLP
Sarah Sorscher, Center for Science in the Public Interest
Stuart TenHoor, Stuart TenHoor Legal Search
Rachel Turow, Skadden, Arps, Slate, Meagher & Flom LLP
Jennifer Zachary, Merck & Co., Inc.
Jessica Zeller, Edwards Lifesciences LLC


























